Subscribe
shutterstock_1291147162_ken_wolter
Ken Wolter / Shutterstock.com
14 April 2020AmericasSarah Morgan

Federal Circuit remands Abbott drug test patent suit

The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary  Alere and patent monetisation company Rembrandt Diagnostics.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Fed Circuit rejects Nobel Prize winner’s patent appeal
16 July 2020   A US federal court has thrown out an appeal from Ono Pharmaceutical and a Nobel Prize-winning immunologist, in a dispute over who made groundbreaking discoveries in cancer therapy.
Americas
Fed Circuit resuscitates heart monitoring patent
20 April 2020   The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.
Americas
Abbott scores case-ending sanctions against wholesaler
26 March 2020   Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.


Editor's picks

Why US patent reform is ‘essential’ for US economic prosperity and security
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

Editor's picks

Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

More on this story

Big Pharma
Fed Circuit rejects Nobel Prize winner’s patent appeal
16 July 2020   A US federal court has thrown out an appeal from Ono Pharmaceutical and a Nobel Prize-winning immunologist, in a dispute over who made groundbreaking discoveries in cancer therapy.
Americas
Fed Circuit resuscitates heart monitoring patent
20 April 2020   The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.
Americas
Abbott scores case-ending sanctions against wholesaler
26 March 2020   Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.

More on this story

Big Pharma
Fed Circuit rejects Nobel Prize winner’s patent appeal
16 July 2020   A US federal court has thrown out an appeal from Ono Pharmaceutical and a Nobel Prize-winning immunologist, in a dispute over who made groundbreaking discoveries in cancer therapy.
Americas
Fed Circuit resuscitates heart monitoring patent
20 April 2020   The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.
Americas
Abbott scores case-ending sanctions against wholesaler
26 March 2020   Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.

More features

UPC orders 17-country ban on EOFlow's pumps in Insulet feud
US warns of rising counterfeit drug threat from India and China
Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit
Biotech and healthcare expert returns to Latham & Watkins
AstraZeneca to appeal invalidated diabetes patent in generics dispute
Why US patent reform is ‘essential’ for US economic prosperity and security
Medical company sees $452m trade secrets award cut by 87%
Fed Circ: Generic doesn’t infringe Metacel MS drug